Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2000; 84(04): 723-724
DOI: 10.1055/s-0037-1614094
DOI: 10.1055/s-0037-1614094
Letters to the Editor
Prevalence of Factor V Leiden Mutation in Yugoslav Thrombophilic Patients and Its Relationship to the Laboratory Diagnosis of APC Resistance
Authors
This work was supported by “Libertas”, pharmaceutical company, Belgrade, Yugoslavia.
Further Information
Publication History
Received
14 February 2000
Accepted after revision
03 May 2000
Publication Date:
11 December 2017 (online)
-
References
- 1 Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in the majority of thrombophilic patients. Blood 1993; 82: 1989-93.
- 2 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
- 3 Bertina RM, Koeleman BPC, Koster T, Rosendal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
- 4 Dahlback B. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis. Thromb Haemost 1997; 78: 483-8.
- 5 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
- 6 Moerloose P, Bounemaux HR, Mannucci PM. Screening Tests for Thrombophilic Patients: Which Tests, for which Patient, by Whom, When, and Why?. Semin Thromb Hemost 1998; 24 (04) 321-7.
- 7 Bertina MR. Laboratory Diagnosis of Resistance to Activated Protein C (APC-Resistance). Thromb Haemost 1997; 78 (01) 478-82.
- 8 Williamson D, Brown K, Luddington R, Baglin C, Baglin T. Factor V Cambridge: A new mutation (Arg 306→Thr) associated with resistance to activated protein C. Blood 1998; 91: 1140-4.